These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3212749)

  • 1. Production of plasminogen activator by alveolar macrophages in normal subjects and patients with interstitial lung disease.
    Robinson BW
    Thorax; 1988 Jul; 43(7):508-15. PubMed ID: 3212749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease.
    Chapman HA; Allen CL; Stone OL
    Am Rev Respir Dis; 1986 Mar; 133(3):437-43. PubMed ID: 3954252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation.
    Chapman HA; Stone OL; Vavrin Z
    J Clin Invest; 1984 Mar; 73(3):806-15. PubMed ID: 6368589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between alveolar macrophage plasminogen activator activity and indices of lung function in young cigarette smokers.
    Reilly JJ; Chapman HA
    Am Rev Respir Dis; 1988 Dec; 138(6):1422-8. PubMed ID: 3202497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic analysis of alveolar macrophages in normal subjects and in patients with interstitial lung disease.
    Campbell DA; Poulter LW; Du Bois RM
    Thorax; 1986 Jun; 41(6):429-34. PubMed ID: 3787519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased alveolar plasminogen activator in early asbestosis.
    Cantin A; Allard C; Bégin R
    Am Rev Respir Dis; 1989 Mar; 139(3):604-9. PubMed ID: 2923358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of plasminogen activator and plasminogen activator inhibitors by alveolar macrophages in control subjects and AIDS patients.
    Angelici E; Contini C; Romani R; Epifano O; Serra P; Canipari R
    AIDS; 1996 Mar; 10(3):283-90. PubMed ID: 8882668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking and interstitial lung disease. The effect of cigarette smoking on the incidence of pulmonary histiocytosis X and sarcoidosis.
    Hance AJ; Basset F; Saumon G; Danel C; Valeyre D; Battesti JP; Chrétien J; Georges R
    Ann N Y Acad Sci; 1986; 465():643-56. PubMed ID: 3488004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchoalveolar macrophages in sarcoidosis and cryptogenic fibrosing alveolitis.
    du Bois RM; Townsend PJ; Cole PJ; Haslam PL; Turner-Warwick M
    Clin Allergy; 1981 Sep; 11(5):409-19. PubMed ID: 7318160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolytic activity in bronchoalveolar lavage of baboons with diffuse alveolar damage: trends in two forms of lung injury.
    Idell S; James KK; Coalson JJ
    Crit Care Med; 1992 Oct; 20(10):1431-40. PubMed ID: 1395665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procoagulant and plasminogen activator activities of bronchoalveolar fluid in patients with pulmonary sarcoidosis.
    Hasday JD; Bachwich PR; Lynch JP; Sitrin RG
    Exp Lung Res; 1988; 14(2):261-78. PubMed ID: 3371278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome.
    Idell S; James KK; Levin EG; Schwartz BS; Manchanda N; Maunder RJ; Martin TR; McLarty J; Fair DS
    J Clin Invest; 1989 Aug; 84(2):695-705. PubMed ID: 2788176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-1 and IL-1 inhibitory activity in the culture supernatants of alveolar macrophages from patients with interstitial lung diseases.
    Nagai S; Aung H; Takeuchi M; Kusume K; Izumi T
    Chest; 1991 Mar; 99(3):674-80. PubMed ID: 1995225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The distribution of procoagulant and plasminogen activator activities among density fractions of normal rabbit alveolar macrophages.
    Sitrin RG; Brubaker PG; Shellito JE; Kaltreider HB
    Am Rev Respir Dis; 1986 Mar; 133(3):468-72. PubMed ID: 3954254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities of pathways of fibrin turnover in lung lavage of rats with oleic acid and bleomycin-induced lung injury support alveolar fibrin deposition.
    Idell S; James KK; Gillies C; Fair DS; Thrall RS
    Am J Pathol; 1989 Aug; 135(2):387-99. PubMed ID: 2476934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alveolar macrophage plasminogen activator.
    Schuyler M; Forman W
    Exp Lung Res; 1984; 6(2):159-69. PubMed ID: 6378611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous production of fibronectin by alveolar macrophages in patients with scleroderma.
    Kinsella MB; Smith EA; Miller KS; LeRoy EC; Silver RM
    Arthritis Rheum; 1989 May; 32(5):577-83. PubMed ID: 2719731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of plasminogen activator activity within normal and injured lungs by in situ zymography.
    Nishiuma T; Sisson TH; Subbotina N; Simon RH
    Am J Respir Cell Mol Biol; 2004 Nov; 31(5):552-8. PubMed ID: 15284078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local abnormalities of coagulation and fibrinolytic pathways that promote alveolar fibrin deposition in the lungs of baboons with diffuse alveolar damage.
    Idell S; Peters J; James KK; Fair DS; Coalson JJ
    J Clin Invest; 1989 Jul; 84(1):181-93. PubMed ID: 2738151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular origin of pro-coagulant and (anti)-fibrinolytic factors in bleomycin-injured lungs.
    Wygrecka M; Markart P; Ruppert C; Petri K; Preissner KT; Seeger W; Guenther A
    Eur Respir J; 2007 Jun; 29(6):1105-14. PubMed ID: 17331968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.